The GT6 glycosyltransferases gene family, that includes the AB0 blood group, shows a complex evolution pattern, with multiple events of gain and loss in different mammal species. In humans the ABO gene is considered the sole functional member although the 0 allele is null and is fixed in certain populations. Here, we analyze the human GT6 pseudogene sequences (Forssman, IGB3, GGTA1, GT6m5, GT6m6, and GT6m7) from an evolutionary perspective, by the study of i) their diversity levels in populations through the resequencing analysis of European and African individuals, ii) the interpopulation differentiation, with genotyping data from a survey of populations covering most of human genetic diversity and iii) the interespecific divergence, by the comparison of the human and some other primate species sequences. Since pseudogenes are expected to evolve under neutrality, they should show an evolutionary pattern different to that of functional sequences, with higher levels of diversity as well as a ratio of synonymous to non synonymous changes close to 1. We describe some departures from these expectations, including selection for inactivation in IGB3, GGTA1 and in the interesting case of FS (Forssman) with a probable shift of its initial function in the primate lineage, which put it apart from a pure neutral pseudogene. These results suggest that some of these GT6 human pseudogenes may still be functional and retain some valuable unknown function in humans, in some case even at the protein level. The evolutionary analysis of all members of the GT6 family in humans allows an insight in their functional history, a process likely due to the interaction of the host glycans that they synthesize with pathogens; the past process that can be unravelled through the footprints left by natural selection in the extant genome variation.
Introduction
The classical definition of pseudogenes as non-functional sequences requires to be revised under the light of the recent advances in the transcriptome and regulatory roles of non-coding RNA. Indeed, recent transcriptome analyses have shown that not only coding regions are transcribed into RNA, but also a high proportion of non-coding regions. This proportion ranges from ~ 15 % of the sequence obtained in the analysis of ten human chromosomes (CHENG et al. 2005 ) to the 93 % described at some ENCODE regions (BIRNEY et al. 2007) , where at least a fifth of the 201 annotated pseudogenes have been demonstrated to be transcribed (ZHENG et al. 2007) . Although the transcription of a pseudogene is not a direct demonstration that the transcripts have biological function, it has been unequivocally demonstrated that the nNOS synthesis is suppressed by an antisense mRNA encoded by a pseudogene in Lymnaea stagnalis (KORNEEV et al. 1999) , and that pseudogene and functional Mkrn1 sequences are competitors for transcription repressors and RNA-digesting enzymes in the mouse (HIROTSUNE et al. 2003; LEE 2003) . Besides such direct functional roles, pseudogene sequences may be involved in gene conversion or recombination events with functional genes, thus acting as a genetic diversity reservoir (BALAKIREV and AYALA 2003; VARGAS-MADRAZO et al. 1995) . Symmetrically, the gene conversion from the functional gene to the pseudogene could limit the deterioration of the pseudogene sequence. Finally, pseudogenes were proposed to be considered as potogenes (BROSIUS and GOULD 1992) due to their potential for becoming new genes (BALAKIREV and AYALA 2003) .
In this work, we analyze the intra and interspecific variability (polymorphisms and divergence) pattern of a set of six human pseudogenes belonging to the glycosyltransferase 6 (GT6) family. This family includes enzymes contributing to the at Pennsylvania State University on February 23, 2013 http://glycob.oxfordjournals.org/ Downloaded from synthesis of histo-blood group-related antigens by transferring a galactose or an Nacetylgalactosamine to different substrates (TURCOT-DUBOIS et al. 2007) . The ABO gene, the most representative gene of this family, has two functional alleles called A and B responsible for the expression of the A or B blood groups, respectively. Even much before of the molecular characterization of the ABO gene (YAMAMOTO et al. 1990 ), phenotypic variation controlled by this locus was used in population genetics analysis, revealing a high level of polymorphism (MOURANT 1970) . Resequencing analysis has greatly extended the number of alleles, showing that this locus exhibits high levels of variation, requiring other forces than neutrality to be explained (AKEY et al. 2004; CALAFELL et al. 2008; STAJICH and HAHN 2005) . Although balancing selection is the best explanation for the ABO gene diversity, the selective agent(s) favouring this pattern remains unknown. Several possible causative agents have been proposed, because of significant associations between some alleles with sensibility to infectious diseases (BOREN et al. 1993; FRY et al. 2008; LINDESMITH et al. 2003; MARIONNEAU et al. 2002; ROWE et al. 2007; RUIZ-PALACIOS et al. 2003; SWERDLOW et al. 1994 ). This was recently reported for the malaria parasite Plasmodium falciparum by a case-control study (Fry et al, 2008) . The association between ABO and the severity of malaria could be responsible of the consistency between the geographical distributions of the ABO alleles and that of the parasite (CSERTI and DZIK 2007) .
Apart of the ABO gene, other members of the GT6 family are present in all vertebrates, and an expansion occurred in the placental mammals (TURCOT-DUBOIS et al. 2007) . In this clade, seven members have been identified and classified into the GT6 family: ABO, Forssman (FS), IGB3, GGTA1, GT6m5, GT6m6, and GT6m7. To the best of our knowledge, not much is known on the function of GT6m5, GT6m6, and GT6m7 genes. These genes show a complex phylogenetic pattern of activity / inactivity at Pennsylvania State University on February 23, 2013 http://glycob.oxfordjournals.org/ Downloaded from with several episodes of gain and loss among mammal species (TURCOT-DUBOIS et al. 2007 ). In particular, ABO is the sole gene to have functional alleles in humans. In humans, FS and GGTA1 are inactivated by several mutations within the coding region including the catalytic domain, while IGB3 displays promoter alteration and aberrant splicing; GT6m5 and GT6m6 are deleted (MILLAND et al. 2006; TURCOT-DUBOIS et al. 2007; XU et al. 1999) , and GT6m7 is probably inactivated by a premature stop codon in the last exon suggesting that the human protein (if it exists) could be not functional.
Because carbohydrates at the cell surface of mammals are used by various pathogens as receptors, the inactivation of some glycosyltransferase genes could have been directly selected as resistance factors (ELLIOTT et al. 2003; MARIONNEAU et al. 2005; MARTIN et al. 2005 In this work we analyze all non-functional members of the GT6 family found in humans including the four non-processed pseudogenes FS, IGB3, GGTA1 and GT6m7, and two processed pseudogenes: LOC401913, a processed ABO copy on chromosome 19 (YAMAMOTO et al. 1990) , and HGT2, a retrotranscript of GGTA1 present in all primates except in prosimians (KOIKE et al. 2007) . The evolutionary analysis of all members of the GT6 family in humans allows to have an insight in their functional history, a process that can be unravelled through the footprints left by natural selection and apparent from inspecting the extant genome variation. To this end, most methods of unravelling the footprint of selection have been used, retrieving signals from very 6 ancient or recent times in the different analysis. Thus this analysis intends to reconstruct the functional history of a gene family composed mostly of pseudogenes. Evolutionary analysis is thus used as a tool in the understanding of biological function.
Methods
There are two kinds of data used: 1) resequencing data, obtained in a sample of European and African individuals, and 2) SNP data from the regions of interest obtained in a world-wide sample.
Samples
For sequencing, nineteen African samples (ten Baoulés and nine defined as Ivorians) and 26 European samples (from Toulouse, France) were sequenced for the region homologous to ABO exon 7 of FS, GGTA1, GT6m7, and IGB3 pseudogenes.
Samples used for each pseudogene are shown in Table S1 (Supplementary material).
SNP genotyping was performed on the 1,064 samples included in the Human Genome Diversity Panel of cell lines (HGDP-CEPH), which belong to 51 populations globally distributed (CANN et al. 2002) . Following the recommendation of Rosenberg (2006) we have used for further analysis the H971 subset, obtained after removing the atypical and duplicated samples, and first-degree relatives. Samples with more than 50% of genotyping missing data have been also excluded from the analysis. The 51 original populations were reorganized in 39 populations, following geographic and ethnic criteria (GONZALEZ-NEIRA et al. 2006 ).
Sequencing and Sequence Analysis
A list of PCR and sequencing primers is provided in Table S2 (Supplementary material). These primers were used to amplify human and in the case of IGB3 chimpanzee DNA. Resulting amplified products were separated on agarose gels, purified using QIAquick PCR Purification Kit (Quiagen, Courtaboeuf, France) and directly sequenced on both strands by using either the fluorescent Dye Terminator method and an ABI 373 automatd sequencer (Applied-Biosystems, Courtaboeuf, France) or the Beckman Coulter sequencing kit (CEQ DTCS-Quick Start) and a CEQ 8000 sequencing apparatus (Beckman Coulter).
Multiple sequence alignments were performed with ClustalW (THOMPSON et al. 1994) . Although the analyzed sequences are considered pseudogenes, the divergence among the paralogous sequences was not a difficulty and totally unambiguous alignments were produced for the five sequences (the four processed pseudogenes and Wu's H, Fu's Fs) have been calculated using DNAsp 4.00 (ROZAS et al. 2003) . The significance of these tests has been estimated by means of coalescent simulations performed using the COSI software, under a realistic human past demography (SCHAFFNER et al. 2005) . 10,000 replicates have been performed. Simulations were performed by considering the recombination rate r, obtained for each region from HapMap (www.hapmap.org). Different individuals have been sequenced for different genome regions (Table S1 ) and thus comparisons may be based on different individual sets. The time to the most recent ancestor (TMRCA) was estimated by means of the maximum likelihood coalescent-based method implemented in the Genetree program (TAVARE et al. 1997) .
Ortologous sequences in macaque (Macaca mulatta), rat (Rattus norvegicus), mouse (Mus musculus) and dog (Canis familiaris) of ABO, FS, GGTA1, GT6m7 and IGB3 were obtained from the GenBank (http://www.ncbi.nlm.nih.gov/) and Ensembl databases (http://www.ensembl.org/index.html). Phylogenetic analyses were performed using the PAML software package (YANG 1997) .
SNPs
We genotyped a total of 43 SNPs in five pseudogene regions (FS, GT6m7, HGT2, IGB3 and LOC401913). Valid genotypes were obtained for 40 of the 43 SNPs.
The exact position of each SNP is shown in Table S3 (Supplementary material). SNPs were selected from HapMap Phase I and dbSNP databases, following a common rationale. We selected SNPs in the genic and 5' and 3' flanking regions (up to 30 kb), with a density of 1SNP / 5 Kb approximately and giving priority to those with a minimum allele frequency (MAF) over 0.1. Ancestral alleles were inferred from the chimpanzee genome sequence (panTro2). SNPs were typed using the SNPlex Genotyping System from Applied Biosystems, following the manufacturer's standard protocol. Allele separation was performed on an Applied Biosystems 3730 analyzer and besides the automated allele calling and quality metrics provided by GeneMapper Software 3.5, allele calling was always reviewed manually. Additional publicly available data for 75 SNPs in these five pseudogene regions and the GGTA1 region was retrieved from http://shgc.stanford.edu/hgdp/, which includes genotyping in the Human Genome Diversity Panel samples (HGDP-CEPH) at more than 650,000 SNP loci, obtained with the Illumina BeadStation technology (LI et al. 2008) . 
SNP Data Analysis

Haplotype Estimation and Linkage Disequilibrium Analysis
Haplotype frequencies were estimated using the bayesian algorithm implemented in the PHASE 2 software using the default parameters and 1,000 iterations (STEPHENS et al. 2001) . Network 4.2.0.1 software was used to generate median-joining networks describing possible genealogical relationships among haplotypes in terms of mutational differences (BANDELT et al. 1999) . Haploview software (BARRETT et al. 2005 ) was used to represent and calculate LD, measured as D' or r 2 , between the different SNPs in the different regions.
Haplotype Extension Analysis
The Extended Haplotype Homozygosity (EHH) and the Relative Extended
Haplotype Homozygosity (REHH) for core haplotypes included in the analyzed regions were calculated both for data presented in this work and HapMap data at different genetic distances using the Sweep software (SABETI et al. 2002) and considering the default core definition parameters. The integrated haplotype score (iHS) has been calculated from Haplotter (http://hg-wen.uchicago.edu/selection/haplotter.htm) (VOIGHT et al. 2006) .
Results
Nucleotide sequence variation
The region homologous to ABO exon 7 of four non-processed human pseudogenes (FS, GGTA1, GT6m7 and IGB3) was sequenced in African and European human samples. We detected six polymorphic sites in FS, four in GGTA1, five in GT6m7, and two in IGB3, some previously unreported (Table 1) . Only one deletion of 1bp has been found at position 166 of GT6m7 locus, and the other 16 polymorphisms are single nucleotide substitutions, with transitions (10) being slightly more frequent than transversions (6), and six of them being singletons (38 %) and four of them doubletons (25 %). This abundance of low frequency variants leads to a high level of homozygosity in all four pseudogenes, with a high proportion of individuals homozygous for the major haplotype for the whole tract analyzed: 67% for FS, 79% for GGTA1, 72% for GT6m7, and 93% for IGB3. Haplotypes for each pseudogene have been inferred (see Methods) and are shown in Table 1 . Ancestral haplotypes have been deduced from the chimpanzee sequence. In the case of IGB3, we have obtained the sequence through PCR amplification with the same primers used in humans, since no homologous sequences were found in public databases.
Nucleotide and Haplotype Diversity
The variation observed in the four pseudogene regions resulted in low levels of nucleotide and haplotype diversity (Table 2) , with IGB3 showing the most extreme values with only two singletons described in the African population and no variation at all in Europeans. All genes, except GT6m7, show a higher level of variation in Africa than in Europe, as expected in the out-of-Africa model of modern humans origin (CAVALLI-SFORZA and FELDMAN 2003) (Table 2 ). In the four cases the variability is much lower than that exhibited by the exon 7 of ABO, whose high level of polymorphism has been proposed to be explained by the action of balancing selection (CALAFELL et al. 2008; FRY et al. 2008) . In general the nucleotide diversity values for these pseudogene regions are close or lower than the average obtained for the 322
resequenced genes included in the SeatlleSNPs database (http://pga.mbt.washington.edu/), with average heterozygosity (π) values of 0.0009 in the African population and 0.0007 in the European population.
We have tested whether the amount of variation in these regions show polymorphism levels in accordance with those expected under neutrality or in fact are lower and due to purifying selection acting on them. We performed coalescent simulations with recombination (see Methods) for each region, considering the number of segregating sites (Table 2) . Simulations have been performed considering a demographic scenario that simulates the human population history (SCHAFFNER et al. 2005) . Only in the case of GGTA1 in Africans and in the case of FS in the Europeans the observed π value are lower than expected, although results do not reach statistical significance (P = 0.068 and P = 0.095, respectively). No simulations could be performed for IGB3 in Europeans, due to the lack of polymorphic positions. In order to gain power, as the four regions show low levels of polymorphism, we have also performed the analysis considering the four regions pooled together. The observed nucleotide diversity level in Africans and Europeans are lower than expected, although the differences are again not significant (P = 0.15 and P = 0.25).
Neutrality tests
In 
Population differentiation
Using the resequencing data, we have measured the population differentiation between Africans and Europeans for all described polymorphisms by means of F ST values. Only in the case of one polymorphic site described in FS (position 336) the differences are statistically different from zero (F ST = 0.34). Nonetheless, it is an isolated case, with the rest of SNPs in the region being much lower.
Genotyping data for 115 SNPs in the six pseudogene regions (see Methods) was used to calculate genetic differentiation of these regions across human populations. Linkage disequilibrium structure SNP genotype data in the six pseudogene regions also provide the opportunity of analyzing the linkage disequilibrium (LD) pattern in every population or continental group. In absence of selective pressures, recombination rate is the main force determining the extent of LD at a given region, and thus, we do not expect to find important differences between the LD patterns in different populations. On the other hand, the existence of local selective forces may increase the amount of LD through a selective sweep, leading to different LD patterns between the populations where the selective event has occurred and those where it has not. However, the role in shaping LD of population history, genetic drift and stochastic factors should also be considered.
We used the extended haplotype homozygosity test (EHH), which allows detecting recent selective sweeps by comparing the breakdown of the LD in different haplotypes (SABETI et al. 2002) . We have performed the EHH test using the data obtained here both considering the 39 populations and the seven continental groups, and no significant departures from neutrality have been found in any of them. In order to analyze larger regions we also performed the iHS tests (VOIGHT et al. 2006) to the six pseudogene regions using HapMap data, and again no evidence of recent positive selection events have been found in any of them. The analysis of LD does not show any significant pattern, meaning that there has not been, in recent times, a differential action of positive selection that would act on some populations and not in others.
Interespecific divergence
We have calculated the rate of synonymous to non-synonymous changes in the lineage leading to humans after the split with chimpanzee for the four non-processed pseudogenes: FS, GGTA1, GT6m7 and IGB3. It is important to stress that all these genes are reputed to be pseudogenes in chimpanzee also. In order to calculate the dN/dS ratio we hypothesized that the pseudogenes are transcribed and translated in proteins.
We used the reading frame of the cognate genes in species in which they are known to (Table 5 ).
The two models are compared using the likelihood ratio test with as much degrees of freedom as the number of differences on the parameters estimated (that fits to a χ 2 distribution). With the exception of FS, although the estimated omega values in the human branch are small, they are not statistically different than 1. In the case of FS, we can reject the hypothesis of this sequence evolving neutrally (ω = 1), suggesting functional constraint in the human branch due to the action of purifying selection.
Discussion
We have performed an evolutionary analysis of six human loci phylogenetically related to the ABO gene. According to different types of evidence, these six loci have been previously proposed to be pseudogenes in humans. Because of their lack of function, pseudogenes are expected to evolve under neutrality, since no functional constraints should be acting on them. Thus, the absence of purifying selection can simply be detected as following the expectation of a neutral model, that can be tested and the departures from it interpreted as selective events, which can have taken place at different times of the evolutionary history. First, since divergence from chimpanzee, the rate of synonymous to non-synonymous changes (deduced from the theoretical reading frame of the pseudogenes) should be close to 1, since the theoretical amino acid changes will not have any consequence; second, inter-population differences should also be higher as populations would differentiate only by drift without common functional constraints; third, sequence variation should fit the theoretical neutral models, tested through many different methods and parameters; and finally, nucleotide diversity levels should be higher in pseudogenes than in functional regions because of lack of purifying selection in the ancestors of extant humans. In this work, we describe that some of the analyzed pseudogenes do not fully fit to these predictions, suggesting that purifying selection has been or is still acting on some of these sequences.
Processed pseudogenes seem to be less prone to show signatures of evolutionary conservation than those coming from a duplication event. Indeed, processed pseudogenes have been originated by retrotransposition, which induces in most cases a protein-coding ability loss (ZHENG et al. 2007 ). The two processed pseudogenes included in this work, do not show special signatures of conservation. Both LOC401913
(that has been poorly studied till now) and HGT2 clearly behave as real pseudogenes, with no evolutionary constraints. HGT2 is a pseudogene containing multiple frameshift mutations processed from GGTA1 after the split between haplorrhines and If any coding function is being retained at these loci, then selection could be related with some RNA function or even with the anomalous protein product (see below). Low nucleotide diversity values can also be explained through the action of positive selection (either on the gene or in the surrounding region). After a positive selection event, the genetic variation is reduced in this region, and this will persist until new neutral mutations will reach high frequencies. This time has been estimated to be up to 1 million years (SABETI et al. 2006) . In some cases, we have found support for positive selection in the regions analyzed: GT6m7 in both Africans and Europeans for Fay and Wu H, and FS in Europeans for Tajima's D (Table 3) . However, these results have to be interpreted with caution. The negative value in the Fay and Wu's H test for GT6m7 in the two populations comes from the fact that the majority of individuals carry the derived allele at two of the five polymorphic positions (Table 1) , which, given this low number of polymorphisms in the locus, may have been produced randomly by drift. In the case of the Tajima's D value for FS in European population, no other neutrality test detects positive selection signatures. In addition, the analysis of LD structure and haplotype extension also fails to detect any signature of positive selection.
The synonymous to non-synonymous changes ratio (d N /d S ) analysis performed at the interspecies level also fails to detect any signature of positive selection (that would be more ancient than that detected by intraspecific tests) in any of the pseudogenes. Thus positive selection is ruled out as a main factor having acted in the studied gene regions.
There are, nonetheless, interesting findings of purifying selection. In fact, the analysis of the interespecific divergence suggests different evolutionary histories for the four non-processed pseudogenes. First, GGTA1 and IGB3 do not show signatures of conservation of the protein sequence. GGTA1 has been suggested to be under strong purifying selection in primates except in catarrhines, where it has been demonstrated to be inactive (KOIKE et al. 2002; KOIKE et al. 2007 ). The obtained d N /d S value in the human branch seems to corroborate its inactivity, and with the present evidence purifying selection can be rejected in this locus (Table 5) . Given the functional constraints on this gene in the noncatarrhine species, and the deleterious effect of its absence demonstrated in knock out mice and pigs, this inactivation in catarrhines (including humans) should have been compensated by yielding important different kind of benefits, as may be an enhanced defence against alphaGal-positive pathogens (KOIKE et al. 2007) . IGB3 also shows a relatively high d N /d S (Table 5) , and has previously been shown not to be functional in humans (KEUSCH et al. 2000) . In both cases the inactivation seem to have produced a defective phenotype that makes that their status as pseudogenes (with inactivation) can only be understood if there is some selective advantage in their inactivation, likely related to pathogen resistance. Thus pathogen resistance would not only explain the functional genetic variation but the lack of functionality. On the other hand, GT6m7 shows a lower level of intraspecific variation, although the model assuming neutrality in the human branch can not be statistically rejected. This is in agreement with the existing evidence of inactivity in this locus, with a stop codons disrupting the last exon having been reported in humans (TURCOT-DUBOIS et al. 2007 ).
Finally, the case of FS is especially interesting. The presence or absence of Forssman glycolipid has been related to different levels of susceptibility for several infectious diseases (ELLIOTT et al. 2003; XU et al. 1999) . While several mutations in its catalytic domain do not allow the production of the Forssman glycolipid in humans, FS mRNA has been detected in several tissues, suggesting that this gene is transcribed and may be retaining some biological function. Our results would support functional-related findings, because unexpectedly low d N /d S ratio has been described in the human lineage.
These results could be compatible with the differentiation of the human FS gene with the acquirement of a function differing from the N-acetyl Galactosyltransferase activity of the classical FS synthase reported in other mammals such as dog and mouse.
Interestingly, proteins encoded by human-dog hybrid cDNA demonstrated that the two amino acid substitutions in human are sufficient to inactivate the dog FS activity (XU et al. 1999) . These two mutations are observed in chimpanzee suggesting that the FS loss of enzyme activity preceded the human-chimpanzee split. Therefore it seems reasonable to evoke the possibility that the new acquired function of the FS protein appeared in the common ancestor of human and chimpanzee. In fact the two inactivating mutations are found also in the orangutan and the rhesus FS genes. The macaque belongs to the socalled Forssman negative species, since heterophile Forssmann antigen is absent in its erythrocytes or organs, while a normal heterophile lysin or Forssman antibody is present in its serum. This leads to conclude that ht inactivation of the FS gene is very ancient in the branch leading to humans.
In conclusion, the evolutionary analysis of one set of human pseudogenes belonging to the GT6 family suggests neutrality in some of them but footprints of selection in others, including selection for inactivation and putative acquisition of new functions. The proportion of proposed non functional members of this family in humans is similar or even higher to that reported in other well described gene families as the olfactory and bitter taste receptors families (FISCHER et al. 2005; GILAD et al. 2005; ROUQUIER et al. 1998 ). In the case of the olfactory receptors, the high proportion of 56 % of the members being non functional in humans, has been explained by a relaxation of the functional constraints in this species related with reduced olfactory needs GILAD et al. 2003 ). The GT6 family shows, in addition to the high number of non functional members, a complex pattern of birth-and-death evolution (TURCOT-DUBOIS et al. 2007 ). These features may arise from the implication of these proteins in interactions with pathogens, with different and changing environments favouring the absence of some pathogen receptors (GAGNEUX and VARKI 1999) . Our analysis suggests that some of these putative human pseudogenes while unable to perform the initial function of AB0, are likely to have been selected for inactivation and in the FS locus maybe used as pathogen target, and thus still retaining a biological function. 
